Hi everyone, I will be running the 2025 London Marathon for Aviva Investors charity partner - Action for A-T!

Action for A-T provides support and funds high quality peer reviewed medical research to speed up the process of identifying a cure for Ataxia Telangiectasia (A-T).

A-T is a rare genetic neurological disorder that affects the part of the brain that controls motor movement (intended movement of muscles) and speech. AT also affects the spine and immune system. It usually begins in early childhood before age 5. Symptoms progressively worsen, leading to full-time wheelchair use – usually before the early teens. A-T occurs in approximately 1 in 300,000 live births. However, A-T diagnosis can be delayed or missed due to its similarities with other conditions.

Since 2012, Action for A-T have invested more than £5,600,000 in 57 A-T related research projects which offer hope to the families living with this devastating condition. This has only been possible thanks to your generous support for which we are truly grateful.